Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Marksans Pharma Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]2614.452174.201849.621480.121368.37
Other Operating Revenues8.403.212.5210.727.81
Total Operating Revenues2622.852177.411852.141490.841376.18
      
Other Income70.3850.4259.3141.856.69
Total Revenue2693.222227.831911.451532.691382.88
      
EXPENSES     
Cost Of Materials Consumed753.02667.70612.97540.67419.76
Purchase Of Stock-In Trade574.48444.28314.78163.25311.57
Changes In Inventories Of FG,WIP And Stock-In Trade-183.76-73.86-6.3912.90-136.28
Employee Benefit Expenses350.30293.64239.37220.30197.32
Finance Costs11.6611.209.138.457.99
Depreciation And Amortisation Expenses83.3974.2751.8544.7836.15
Other Expenses600.17387.07352.09294.84244.20
Total Expenses2189.251804.301573.801285.181080.71
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax503.97423.53337.65247.51302.16
      
Profit/Loss Before Tax503.97423.53337.65247.51302.16
      
Tax Expenses-Continued Operations     
Current Tax127.28113.3171.5757.1066.69
Deferred Tax-7.24-5.111.103.59-3.07
Tax For Earlier Years1.310.43-0.330.010.00
Total Tax Expenses121.35108.6372.3360.7063.63
Profit/Loss After Tax And Before ExtraOrdinary Items382.62314.90265.32186.81238.54
      
Profit/Loss From Continuing Operations382.62314.90265.32186.81238.54
      
Profit/Loss For The Period382.62314.90265.32186.81238.54
      
Minority Interest-2.04-1.200.990.000.00
Consolidated Profit/Loss After MI And Associates380.58313.70266.31186.81238.54
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)8.406.926.414.515.76
Diluted EPS (Rs.)8.406.926.414.515.76
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend27.1922.6610.1710.234.09
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]2614.45
Other Operating Revenues8.40
Total Operating Revenues2622.85
Other Income70.38
Total Revenue2693.22
EXPENSES 
Cost Of Materials Consumed753.02
Purchase Of Stock-In Trade574.48
Changes In Inventories Of FG,WIP And Stock-In Trade-183.76
Employee Benefit Expenses350.30
Finance Costs11.66
Depreciation And Amortisation Expenses83.39
Other Expenses600.17
Total Expenses2189.25
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax503.97
Profit/Loss Before Tax503.97
Tax Expenses-Continued Operations 
Current Tax127.28
Deferred Tax-7.24
Tax For Earlier Years1.31
Total Tax Expenses121.35
Profit/Loss After Tax And Before ExtraOrdinary Items382.62
Profit/Loss From Continuing Operations382.62
Profit/Loss For The Period382.62
Minority Interest-2.04
Consolidated Profit/Loss After MI And Associates380.58
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)8.40
Diluted EPS (Rs.)8.40
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend27.19